References

  1. Foerschner AM. "The History of Mental Illness: from skull drills to happy pills." Inquiries Journal/Student Pulse. 2010; 2(9): 1-4. Google Scholar

  2. Deniker Pierre. Psychopharmacologie: les médicaments et drogues psychotropes. Ellipse Paris. 1987; 35.

  3. Louis Léonard, Mohamed Ben Amar. Les psychotropes: pharmacologie et toxicomanie. 2014-2002. Toronto, Ontario: EBOUND Canada. Presses de l'Université de Montréal pg 129. Google Scholar

  4. Joël Ankri, Johanne Collin, Guilhème Pérodeau, Béatrice Beaufils. Médicaments psychotropes et sujets âgés une problématique commune France-Québec? (synthèse de la littérature). Sciences Sociales et Santé. 2002; 20(1): 35-62. Google Scholar

  5. Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC.. A three-country comparison of psychotropic medication prevalence in youth. Child and Adolescent Psychiatry and Mental Health. 2008 Sep 25; 2(1): 26. PubMed | Google Scholar

  6. Asouab F, Agoub M, Kadri N, Moussaoui D, Rachidi S, Tazi MA, Toufiq J, Chaouki N. Prévalence de troubles mentaux dans la population générale marocaine (Enquête nationale, 2005). Royaume du Ministère de la Santé, Direction de l'Epidémiologie et de la Lutte contre les Maladies (D.E.L.M), bulletin épidémiologique. 2007.

  7. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002; 63(9): 817-25. PubMed | Google Scholar

  8. Ronald C, Kessler, Sergio Aguilar-Gaxiola, Jordi Alonso, SomnathChatterji, Sing Lee, Johan Ormel T, BedirhanÜstün, Philip S Wang. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) Surveys. EpidemiolPsichiatr Soc. 2009 Jan-Mar; 18(1): 23-33. PubMed | Google Scholar

  9. Lecadet J, Vidal P, Baris B, Vallier N, Fender P, Allemand H, le groupe Médipath. Médicaments psychotropes: consommation et pratiques de prescription en France métropolitaine, I, Données nationales, 2000. Rev Med Ass Maladie. 2003; 34: 75-84.

  10. Alonso J, Angermeyer MC, Bernert S. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004; 420: 55-64. PubMed | Google Scholar

  11. Hampton LM, Daubresse M, Chang HY, Alexander GC, Budnitz DS. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatr. 2014; 71(9): 1006-1014. PubMed | Google Scholar

  12. Lagnaoui R, Depont F, Fourrier A, Abouelfath A, Bégaud B, Verdoux H, Moore N. Patterns and correlates of benzodiazepine use in the French general population. Eur J ClinPharmacol. 2004; 60(7): 523-9. PubMed | Google Scholar

  13. Chiatti C, Bustacchini S, Furneri G, Mantovani L, Cristiani M, Misuraca C, Lattanzio F. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Saf. 2012; 35(Suppl 1): 73-87. PubMed | Google Scholar

  14. Marquez M, Arenoso H, Caruso N. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders. ActasEspPsiquiatr. 2011; 39(2): 88-94. PubMed | Google Scholar

  15. Nutt D, Ballenger J. Anxiety Disorders. Oxford, UK: Blackwell Science Ltd. 2003.

  16. Romach MK, Busto UE, Sobell LC, Sobell MB, Somer GR, Sellers EM. Long-term alprazolam use: abuse, dependence or treatment. Psychopharmacol Bull. 1991; 27(3): 391-5. PubMed | Google Scholar

  17. Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM. Advances in neuropathic pain: diagnosis, mechanisms and treatment recommendations. Arch Neurol. 2003; 60(11): 1524-1534. PubMed | Google Scholar

  18. Dieuwke S, Veldhuijzen, Albert JM, van Wijck, Joris C, Verster, Leon Kenemans J, Cor J Kalkman, Berend Olivier, Edmund R Volkerts. Acute and subchronic effects of amitriptyline 25 mg on actual driving in chronic neuropathic pain patients. J Pharmacol. 2006; 20(6): 782-788. PubMed | Google Scholar

  19. Sein Anand J, Chodorowski Z, Habrat B. Recreational amitriptyline abuse. PrzeglLek. 2005; 62(6): 397-8. PubMed | Google Scholar

  20. Andreassen OA, Aamo TO, Jorgensen HA. 1996 Inhibition by memantine of the development of persistent oral dyskinesias induced by long term haloperidol treatment of rats. Br J Pharmacol. 1996 Oct; 119(4): 751-7. PubMed | Google Scholar

  21. Omori IM, Wang J. Sulpiride versus other antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2009 Apr 15;(2): CD007811. PubMed | Google Scholar

  22. Soares BG, Fenton M, Chue P. Sulpiride for schizophrenia. Cochrane Database Syst Rev. 2000; 2: CD001162. PubMed